Depreciation of CATALYST PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CATALYST PHARMACEUTICALS, INC. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CATALYST PHARMACEUTICALS, INC. Depreciation for the quarter ending 31 Mar 2025 was $115,000, a 34% increase year-over-year.
  • CATALYST PHARMACEUTICALS, INC. annual Depreciation for 2025 was $375,000, a 5.5% decline from 2024.
  • CATALYST PHARMACEUTICALS, INC. annual Depreciation for 2024 was $397,000, a 26% increase from 2023.
  • CATALYST PHARMACEUTICALS, INC. annual Depreciation for 2023 was $316,000, a 124% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

CATALYST PHARMACEUTICALS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $375,000 -$22,000 -5.5% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $397,000 +$81,000 +26% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $316,000 +$175,000 +124% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $141,000 -$51,000 -27% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $192,000 +$100,000 +109% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $92,000 +$37,000 +67% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $55,000 +$17,022 +45% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2022 2021 FY
2018 $37,978 -$7,711 -17% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
2017 $45,689 +$2,283 +5.3% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
2016 $43,406 +$8,938 +26% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2018 2017 FY
2015 $34,468 +$7,894 +30% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $26,574 +$4,091 +18% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
2013 $22,483 +$11,594 +106% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $10,889 -$31,946 -75% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $42,835 +$17,094 +66% 01 Jan 2011 31 Dec 2011 10-K 19 Mar 2014 2013 FY
2010 $25,741 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013 2012 FY

CATALYST PHARMACEUTICALS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $115,000 +$29,000 +34% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $86,000 +$17,000 +25% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $69,000 +$35,000 +103% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $34,000 -$63,000 -65% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $97,000 +$83,000 +593% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $14,000 +$252 +1.8% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q3 2019 $6,532 -$2,762 -30% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q1 2019 $43,711 $13,748 +$5,733 +72% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $37,978 $12,493 +$5,558 +80% 01 Oct 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY
Q3 2018 $32,420 $9,294 -$3,545 -28% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $35,965 $8,176 -$4,781 -37% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $40,746 $8,015 -$4,943 -38% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $45,689 $6,935 -$5,029 -42% 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $50,718 $12,839 +$3,357 +35% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $47,361 $12,957 +$4,195 +48% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $43,166 $12,958 -$240 -1.8% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $43,406 $11,964 +$5,878 +97% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 $37,528 $9,482 -$1,777 -16% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $39,305 $8,762 -$213 -2.4% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $39,518 $13,198 +$5,050 +62% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $34,468 $6,086 -$1,885 -24% 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
Q3 2015 $36,353 $11,259 +$4,024 +56% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $32,329 $8,975 +$2,892 +48% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $29,437 $8,148 +$2,863 +54% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $26,574 $7,971 +$2,265 +40% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
Q3 2014 $24,309 $7,235 +$1,528 +27% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $22,781 $6,083 +$377 +6.6% 04 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015 2015 Q2
Q1 2014 $22,404 $5,285 -$79 -1.5% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q4 2013 $22,483 $5,706 +$3,053 +115% 01 Oct 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
Q3 2013 $19,430 $5,707 +$2,982 +109% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 $16,448 $5,706 +$2,996 +111% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 $13,452 $5,364 +$2,563 +92% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 $10,889 $2,653 01 Oct 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
Q3 2012 $2,725 -$4,727 -63% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q2 2012 $2,710 -$18,320 -87% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q2
Q1 2012 $2,801 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q3 2011 $7,452 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q3
Q2 2011 $21,030 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.